Simon Tate - May 19, 2022 Form 4 Insider Report for Eliem Therapeutics, Inc. (ELYM)

Role
Director
Signature
/s/ Brian Woodard, Attorney-in-Fact
Stock symbol
ELYM
Transactions as of
May 19, 2022
Transactions value $
$0
Form type
4
Date filed
6/1/2022, 05:17 PM
Previous filing
Aug 9, 2021
Next filing
May 22, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELYM Stock Option (Right To Buy) Award $0 +10K $0.00 10K May 19, 2022 Common Stock 10K $3.46 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option will vest on the earlier of May 19, 2023 or the day immediately prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service through such date.